Coastal Bridge Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History

Coastal Bridge Advisors's CNTA Position: Q2 2026 in Review

Coastal Bridge Advisors sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 13,102 shares — an estimated $520K sold.

Coastal Bridge Advisors first reported a position in CNTA in Q2 2025 and held it in 4 quarters. The position peaked at $520K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

• Coastal Bridge Advisors reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
• Coastal Bridge Advisors sold 13,102 Centessa Pharmaceuticals shares in Q2 2026, an estimated $520K.
• Coastal Bridge Advisors first reported a position in Centessa Pharmaceuticals in Q2 2025 and held it in 4 quarters.
• Coastal Bridge Advisors's Centessa Pharmaceuticals position peaked at $520K in Q1 2026.
• 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Coastal Bridge Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.